Range Units Cytokine QC Level Expected Range Units
G-CSF Control 1 114 – 236 pg/mL IL-9 Control 1 95 – 196 pg/mL MIP-1 Control 1 110 – 229 pg/mL
Control 2
Range Units Cytokine QC Level Expected Range Units
G-CSF Control 1 114 – 236 pg/mL IL-9 Control 1 95 – 196 pg/mL MIP-1 Control 1 110 – 229 pg/mL
Control 2
Cytokine QC Level Expected Range Units Cytokine QC Level Expected Range Units
Eotaxin Control 1 94 - 196 pg/mL IL-6 Control 1 97 - 201 pg/mL LIX Control 1 109 - 226 pg/mL
Matrices: New Tissue Models for Drug
Toxicology and Cancer Drug Discovery. Adv. Enz.
Reg., 47, 196-207 (2007).
4. Ghosh, K. et al., Cell Adaptation to a
Physiologically Relevant ECM Mimic with Different
Matrices: New Tissue Models for Drug
Toxicology and Cancer Drug Discovery. Adv. Enz.
Reg., 47, 196-207 (2007).
4. Ghosh, K. et al., Cell Adaptation to a
Physiologically Relevant ECM Mimic with Different
Matrices: New Tissue Models for Drug
Toxicology and Cancer Drug Discovery. Adv. Enz.
Reg., 47, 196-207 (2007).
5. Shu, X.Z. et al., In situ crosslinkable hyaluronan
hydrogels for tissue engineering
Matrices: New Tissue Models for Drug
Toxicology and Cancer Drug Discovery. Adv. Enz.
Reg., 47, 196-207 (2007).
5. Shu, X.Z. et al., In situ crosslinkable hyaluronan
hydrogels for tissue engineering
promoter
region of ESR2 gene and breast cancer
susceptibility. J. Steroid Biochem. Mol. Biol.,
114(3-5), 207-211 (2009).
5. Maquire, P. et al. Estrogen receptor beta (ESR2)
polymorphisms in familial and sporadic
Transduction P y y y
206 PKB phosphoserine 473 (pS
473) P4112 Signal Transduction P n/d y y
207 PKB phosphothreonine 308 (pT
308) P3862 Signal Transduction P n/d y y
208 PKC α
P2482 207 AKT1 M NP_001014431.1,NP_001014432.1 , NP_005154.2, y y y
575 Protein Kinase Ba /Akt1 P1601 207 AKT1 P NP_001014431.1,NP_001014432.1 , NP_005154.2, y y y
577 phospho-PKB (pSer473) P4112 207 AKT1
P2482 207 AKT1 M NP_001014431.1,NP_001014432.1 , NP_005154.2, y y y
575 Protein Kinase Ba /Akt1 P1601 207 AKT1 P NP_001014431.1,NP_001014432.1 , NP_005154.2, y y y
577 phospho-PKB (pSer473) P4112 207 AKT1
P2482 207 AKT1 M NP_001014431.1,NP_001014432.1 , NP_005154.2, y y y
575 Protein Kinase Ba /Akt1 P1601 207 AKT1 P NP_001014431.1,NP_001014432.1 , NP_005154.2, y y y
577 phospho-PKB (pSer473) P4112 207 AKT1
001101103.1 M y y y
574 Protein Kinase Bα /Akt1 P2482 207, 11651, 24185 AKT1,Akt1 NP_005154.2,NP_033782.1,NP_150233.1 M y y y
575 Protein Kinase Bα /Akt1 P1601 207, 11651, 24185 AKT1,Akt1 NP_005154.2,NP_033782.1
001101103.1 M y y y
574 Protein Kinase Bα /Akt1 P2482 207, 11651, 24185 AKT1,Akt1 NP_005154.2,NP_033782.1,NP_150233.1 M y y y
575 Protein Kinase Bα /Akt1 P1601 207, 11651, 24185 AKT1,Akt1 NP_005154.2,NP_033782.1
C7785 M y n/d n/d
205 Cytokeratin peptide 7 C6417 M y n/d n/d
206 Cytokeratin 8.12 C7034 M y n/d n/d
207 Cytokeratin 8.13 C6909 M y n/d n/d
208 Cytokeratin peptide 13 C0791 M y n/d n/d
209 Cytokeratin Peptide